Moreover, we found both the AMD and P2G treatment significantly increased the quantity of small blood vessels, which were indicated by circular CD31‐positive staining (Fig. 1C), at 3 weeks post‐treatment and no significant difference between AMD and P2G groups was observed (Fig. 1D). Here, PECAM1 is linked to age-related macular degeneration.